In the United States, people receiving breast cancer treatment had higher mortality risk when they had financial problems versus when they didn’t.
To provide practical approaches to managing cancer pain, the American Society of Clinical Oncology (ASCO) developed a special series of 14 articles on pain in people with cancer, including breast cancer.
A small study suggests that postmenopausal women with partners may have better quality of life than women without partners when experiencing a number of sexual side effects from hormonal therapy.
A national survey of more than 1,000 women diagnosed with metastatic breast cancer found that 35% had no insurance and nearly 70% said they were worried about financial problems because of cancer.
A study suggests that people in hospice and palliative care who listen to live music in their rooms as part of their treatment feel better both emotionally and physically.
A study has found that women diagnosed with early-stage, hormone-receptor-positive breast cancer with no prescription drug coverage were less likely to start hormonal therapy than women who had insurance coverage for prescription drugs.
A large percentage of the difference in breast cancer stage at diagnosis between white women and women of other ethnicities seems to be affected by whether a woman has insurance.
Non-white women have more severe pain with advanced breast cancer than white women.
More than half of women who have breast cancer surgery have continuing pain a year after surgery, according to a Finnish study.
A study found that nearly 33% of women diagnosed with early-stage breast cancer who were working when they began treatment were unemployed 4 years later.
A study suggests that many women are concerned about the cost of breast cancer treatment and feel their doctor's offices aren't helping address these concerns.
Having axillary lymph node surgery and being younger are associated with pain lasting 2 months or more after breast cancer surgery.
Research suggests that Black women diagnosed with stage IV disease are less likely to receive antidepressants and sleep aids than white women.
Two types of acupuncture were better than physical therapy, steroids, and pain medicine usually used to ease ongoing muscle and/or joint pain among cancer survivors.
Twelve years after being diagnosed with breast cancer, women had between $1,000 and $3,300 out-of-pocket medical care costs per year.
A small study has found that mindfulness-based cognitive therapy can help ease the pain that many women continue to have months and years after breast cancer treatment is completed.
A study suggests that Medicaid doesn't really improve the health of people covered, but does increase the use of preventive services and the rate of diabetes diagnoses, while lowering depression rates and reducing the financial stress of paying for healthcare.
A study has found that women diagnosed with advanced-stage breast cancer who wait more than 60 days to start treatment have a much higher risk of dying from breast cancer than women who start treatment earlier.
The FDA approved Intrarosa to treat pain during sexual intercourse, but it's not clear if the product is safe for women who've been diagnosed with breast cancer.
Research shows that about half of women who have breast cancer surgery have continuing pain problems a year or more after surgery.
To help doctors and patients understand which complementary therapies are safe and effective for people diagnosed with breast cancer, the Society for Integrative Oncology has published guidelines.
A study has found that household net worth has a big effect on whether women will stick to their hormonal therapy treatment plans.
A small study has found that applying a lidocaine compress to the area where the vulva meets with the vagina can make intercourse comfortable again for women who've been treated for breast cancer.
A small study suggests that Estring and vaginal testosterone cream seem safe and effective for postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer who are taking an aromatase inhibitor and experiencing vaginal dryness and/or loss of libido.